Gender-affirming hormone therapy may increase risk of high blood pressure

Transgender and gender-diverse people have higher rates of hypertension compared to the general population. Within two to four months of starting gender-affirming hormone therapy, transgender women had a lower average systolic blood pressure, and transgender men had a higher average systolic blood pressure.